Original Research
Accepted on 21 Apr 2025
A Novel Tc17 Population Recruited by Tumor Cells Promotes Tumor Progression in Gastric Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1592328
Type at least 3 characters
1,408 articles
Review
Accepted on 17 Apr 2025
Advances in Neoantigen-based Immunother apy for Head and Neck Squamous Cell Car cinoma (HNSCC): A Compr ehensive Review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1593048
- 110 views
Case Report
Accepted on 17 Apr 2025
Acral vasculitis induced by Immune Checkpoint Inhibitor : case series and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1537825
- 117 views
Case Report
Published on 16 Apr 2025
Case Report: A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1517391
- 266 views
Original Research
Accepted on 14 Apr 2025
Combined Stereotactic Radiation Therapy and Immunotherapy for Metastatic Uveal Melanoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1567504
- 135 views
Original Research
Accepted on 14 Apr 2025
Neutrophil/lymphocyte ratio (NLR): a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1557652
- 116 views
Original Research
Accepted on 10 Apr 2025
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1579214
Mini Review
Published on 09 Apr 2025
Activation-induced cytidine deaminase in tertiary lymphoid structures: dual roles and implications in cancer prognosis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1555491
- 268 views
Mini Review
Published on 09 Apr 2025
Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1566202
- 294 views
Mini Review
Published on 09 Apr 2025
Single-cell RNA sequencing in diffuse large B-cell lymphoma: tumor heterogeneity, microenvironment, resistance, and prognostic markers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1583250
- 329 views
Brief Research Report
Published on 08 Apr 2025
Amyloid precursor-like protein 2 expression in macrophages: differentiation and M1/M2 macrophage dynamics
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1570955
- 350 views
Editorial
Accepted on 07 Apr 2025
Editorial: The Tumor Microenvironment and Immunotherapy for Head and Neck Tumors
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1606787
Editorial
Published on 07 Apr 2025
Editorial: Mitochondria in the regulation of anti-tumor immunity
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1596146
- 199 views
Original Research
Accepted on 04 Apr 2025
Deciphering ERR Family Genes as Prognostic and Immunological Biomarkers through Pan-Cancer Analysis with Validation in Gallbladder Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1525635
- 104 views
Case Report
Published on 03 Apr 2025
Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1485386
- 506 views
Review
Published on 03 Apr 2025
Combination therapy with oncolytic viruses for lung cancer treatment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2025.1524079
- 728 views